DNA and protein HIV vaccines: how should we mix it?
Lancet HIV
.
2024 May;11(5):e274-e275.
doi: 10.1016/S2352-3018(24)00092-4.
Author
Yves Levy
1
Affiliation
1
Groupe Henri-Mondor Albert-Chenevier, AP-HP, Créteil, France; Vaccine Research Institute, INSERM U955, Université Paris-Est Créteil, 94010 Créteil, France. Electronic address: yves.levy@aphp.fr.
PMID:
38692821
DOI:
10.1016/S2352-3018(24)00092-4
No abstract available
MeSH terms
AIDS Vaccines* / immunology
HIV Infections* / prevention & control
HIV-1 / immunology
Humans
Vaccines, DNA*
Substances
AIDS Vaccines
Vaccines, DNA